Fla. cancer center pays $12 million in fraud settlement

Mar 23, 2010

The U.S. Department of Justice announced yesterday that a large multispecialty physician group in Florida has agreed to pay $12 million to settle allegations that it submitted false reimbursement claims for radiation oncology treatments to federal healthcare agencies.

Click here to read the rest of the article.

Latest in Radiation Oncology/Therapy
Graph Financial Results Tablet 400
Radiopharmaceutical therapy use increased 20-fold over a decade
February 19, 2026
Prostate Imaging
Pooled evidence: Lu-177 PSMA-617 vs. established therapies in mCRPC
February 18, 2026
Radiation Treatment Cancer 400
UNC Health to install Mevion’s proton therapy system
February 17, 2026
2026 02 13 Port Fractures Thumbnail
Study questions routine use of radiotherapy after bone surgery
February 13, 2026
Related Stories
2009 03 25 14 14 33 939 Capitol Hill 70
Digital X-Ray
Medical groups tell Congress more radiation rules are needed
2009 11 12 17 39 08 655 2009 03 02 Radioactive Symbol
Nuclear Medicine
FDA launches initiative to rein in medical radiation
2009 03 25 14 14 33 939 Capitol Hill 70
Digital X-Ray
Congress sets hearing to review medical radiation
2009 01 15 16 03 49 510 Med Phys Web Logo 100
Radiation Oncology/Therapy
Radiation therapy markers may have role in drug delivery
More in Radiation Oncology/Therapy
Radiopharmaceutical therapy use increased 20-fold over a decade
By Will Morton
Intravenous administrations of cancer therapies such as Xofigo, Lutathera, and Pluvicto have increased by more than 2000%.
February 19, 2026
Graph Financial Results Tablet 400
Pooled evidence: Lu-177 PSMA-617 vs. established therapies in mCRPC
By Will Morton
Lu-177 PSMA-617 has a 36% relative reduction in risk of progression versus standard therapies.
February 18, 2026
Prostate Imaging
UNC Health to install Mevion’s proton therapy system
By AuntMinnie.com staff writers
UNC Health will install Mevion's S250-FIT after converting a treatment room to support proton therapy in its established oncology ecosystem.
February 17, 2026
Radiation Treatment Cancer 400
Study questions routine use of radiotherapy after bone surgery
By Will Morton
Findings suggest a possible hazard associated with postoperative radiotherapy.
February 13, 2026
2026 02 13 Port Fractures Thumbnail
Siemens, Northwestern to collaborate on precision cancer care
By AuntMinnie.com staff writers
The two organizations plan to establish a global center of excellence in theranostics.
February 9, 2026
Siemens
Public-private EU consortium awarded $18M for cancer research
By AuntMinnie.com staff writers
The PreciseOnco consortium has been awarded $17.6 million from the EU’s Innovative Health Initiative for precision cancer treatment.
February 4, 2026
Radiologist Breast Imaging Computer Screen
ASTRO and ESTRO mark World Cancer Day
By AuntMinnie.com staff writers
Today’s radiotherapy is a far more precise, effective, and patient-centered treatment than ever before, according to the groups.
February 4, 2026
Cancertarget
Nucs AI establishes medical advisory board
By AuntMinnie.com staff writers
Nucs AI has formed its medical advisory board to ensure the company's AI theranostics tech is aligned with clinical practice.
January 29, 2026
Ai Abstract Researcher (1)
ASTRO launches national radiopharmaceutical therapy training centers
By AuntMinnie.com staff writers
ASTRO has launched a national program creating Authorized User Training Centers for radiopharmaceutical therapy education.
January 29, 2026
Radiotherapy 400
Nuclidium wins patent for Cu-61-based radiodiagnostic program
By AuntMinnie.com staff writers
The patent protects the copped-61 (Cu-61)-based diagnostic as well as its use in combination with Cu-67.
January 26, 2026
Cu Copper Periodic Table Element Adobe Digital Equilibrium
Elekta secures U.S. FDA 510(k) clearance for Evo
By AuntMinnie.com staff writers
The company is moving forward with Elekta Evo CT-Linac.
January 16, 2026
Radiation Therapy Suite 400 l Tms5 W Hgx Q
Alliance for Clinical Trials in Oncology launches prostate cancer trial
By AuntMinnie.com staff writers
The phase III trial, called RECIPROCAL, will include 1,500 patients with metastatic, castration-resistant prostate cancer.
January 5, 2026
Radiation Therapy Suite
Page 1 of 468
Next Page